Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Long Yu

Showing results (1361-1370 of 1,392) with videos related to

Pageof 140
Sort By:
Journal of Cachexia, Sarcopenia and Muscle|February 2, 2022
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive reviewChun-Wei Li, Kang Yu, Ng Shyh-Chang, et al.
Journal of Cancer|November 19, 2019
Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinomaXiwen Liao, Tingdong Yu, Chengkun Yang, et al.
International Journal of Cancer|April 11, 2012
Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studiesFang-Hui Zhao, Adam K Lewkowitz, Shang-Ying Hu, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Orally active fusion inhibitor of respiratory syncytial virusChristopher Cianci, Kuo-Long Yu, Keith Combrink, et al.
Bioorganic & Medicinal Chemistry Letters|July 10, 2007
Respiratory syncytial virus fusion inhibitors. Part 6: an examination of the effect of structural variation of the benzimidazol-2-one heterocycle moietyKeith D Combrink, H Belgin Gulgeze, Jan W Thuring, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 13, 2016
miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patientsGuopeng Yu, Qianyi Xiao, Xiao-Pin Ma, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 28, 2016
MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinomaXiao-Pin Ma, Guopeng Yu, Xubo Chen, et al.
Journal of Cancer|July 11, 2019
Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinomaXiwen Liao, Xiangkun Wang, Ketuan Huang, et al.
Nature Medicine|August 15, 2017
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activationPingzhao Zhang, Dejie Wang, Yu Zhao, et al.
Scientific Reports|November 17, 2015
Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control studyJuan Wen, Ci Song, Deke Jiang, et al.
Pageof 140

Showing results (1361-1370 of 1,392) with videos related to

Sort By:
Pageof 140
Journal of Cachexia, Sarcopenia and Muscle|February 2, 2022
Pathogenesis of sarcopenia and the relationship with fat mass: descriptive reviewChun-Wei Li, Kang Yu, Ng Shyh-Chang, et al.
Journal of Cancer|November 19, 2019
Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinomaXiwen Liao, Tingdong Yu, Chengkun Yang, et al.
International Journal of Cancer|April 11, 2012
Prevalence of human papillomavirus and cervical intraepithelial neoplasia in China: a pooled analysis of 17 population-based studiesFang-Hui Zhao, Adam K Lewkowitz, Shang-Ying Hu, et al.
Antimicrobial Agents and Chemotherapy|January 27, 2004
Orally active fusion inhibitor of respiratory syncytial virusChristopher Cianci, Kuo-Long Yu, Keith Combrink, et al.
Bioorganic & Medicinal Chemistry Letters|July 10, 2007
Respiratory syncytial virus fusion inhibitors. Part 6: an examination of the effect of structural variation of the benzimidazol-2-one heterocycle moietyKeith D Combrink, H Belgin Gulgeze, Jan W Thuring, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 13, 2016
miR-492G>C polymorphism (rs2289030) is associated with overall survival of hepatocellular carcinoma patientsGuopeng Yu, Qianyi Xiao, Xiao-Pin Ma, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 28, 2016
MiR-608 rs4919510 is associated with prognosis of hepatocellular carcinomaXiao-Pin Ma, Guopeng Yu, Xubo Chen, et al.
Journal of Cancer|July 11, 2019
Integrated analysis of competing endogenous RNA network revealing potential prognostic biomarkers of hepatocellular carcinomaXiwen Liao, Xiangkun Wang, Ketuan Huang, et al.
Nature Medicine|August 15, 2017
Intrinsic BET inhibitor resistance in SPOP-mutated prostate cancer is mediated by BET protein stabilization and AKT-mTORC1 activationPingzhao Zhang, Dejie Wang, Yu Zhao, et al.
Scientific Reports|November 17, 2015
Hepatitis B virus genotype, mutations, human leukocyte antigen polymorphisms and their interactions in hepatocellular carcinoma: a multi-centre case-control studyJuan Wen, Ci Song, Deke Jiang, et al.
Pageof 140